SFTPD and triple-negative breast carcinoma: Indeed, the presence of SP-D was evident in cytoplasmic labeling and was highly expressed by the ductal epithelium of peritumoral mammary parenchyma and the neoplastic subclones of luminal A type, while its reduced expression was evident in triple-negative breast cancer (TBNC) (Figure 4A).